<!DOCTYPE html>
<html lang="en">
<head><!-- Google Tag Manager --> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-N4XZHNC');</script> <!-- End Google Tag Manager -->

<title>Pharmacology of Drugs in Urology</title>
  <meta charset="utf-8">
  
  <link href="urology2.css" rel="stylesheet">

<meta name="keywords" content="pharmacology, drugs, urology drugs, medication, side effects, contraindication, dosage" >
<meta name="description" content="mechanism of action, side effects, contraindications and dosage of drugs in urology, from the online textbook of urology by D. Manski" >
<meta name="author" content="Dr. med. Dirk Manski" >
<meta name="copyright" content="Dirk Manski" >
<meta name="robots" content="index">
<meta name="robots" content="follow">
<meta name="viewport" content="width=device-width, initial-scale=1">
 </head>

<body><!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-N4XZHNC" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
<header>
    <a class="ribbon" tabindex="-1" title="back to start!" href="https://www.urology-textbook.com/index.html">
	   <p><big>Urology-Textbook.com</big><br>
       <br>
       <small>Up-to-date urology insights from Dirk Manski</small></p>
    </a>  
</header>
<main> 
<article>
<nav role="navigation">
<div id="menuToggle">
<input type="checkbox" id="menuCheckbox" />
     <span></span>
    <span></span>
    <span></span>
<ul id="menu">
<li>
        <a href="https://www.urology-textbook.com/anatomy.html">
          <label for="menuCheckbox" onclick="this.parentNode.click();">Anatomy</label>
        </a>
      </li>
<li><a href="https://www.urology-textbook.com/signs-and-symptoms.html">Signs and Symptoms</a></li>
<li><a href="https://www.urology-textbook.com/examinations.html">Examinations</a></li>
<li><a href="https://www.urology-textbook.com/surgical-management.html">Surgical Management</a></li>
<li><a href="https://www.urology-textbook.com/pharmacology.html">Pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></li>
<li><a href="https://www.urology-textbook.com/ureters.html">Ureters</a></li>
<li><a href="https://www.urology-textbook.com/bladder.html">Bladder</a></li>
<li><a href="https://www.urology-textbook.com/prostate.html">Prostate</a></li>
<li><a href="https://www.urology-textbook.com/urethra.html">Urethra</a></li>
<li><a href="https://www.urology-textbook.com/penis.html">Penis</a></li>
<li><a href="https://www.urology-textbook.com/testes.html">Testes</a></li>
<li><a href="https://www.urology-textbook.com/adrenal-glands.html">Adrenal Glands</a></li>
<li><a href="https://www.urology-textbook.com/common-diseases.html">Common Diseases</a></li>
<li><a href="https://www.urology-textbook.com/urologic-surgery.html">Urologic Surgery</a></li>
<li><a href="https://www.urology-textbook.com/index-urology.html">Index</a></li>
<li><a href="https://www.urology-textbook.com/medical-abbreviations.html">Abbreviations</a></li>
<li><a href="https://www.urology-textbook.com/urology-news.html">News</a></li>
<li><a href="https://www.urology-textbook.com/links.html">Links</a></li>
</ul>


</div>
</nav>

<p id="brotkrumen">&nbsp;You are here: <a href="https://www.urology-textbook.com/index.html">Urology Textbook</a> &gt; Pharmacology</p>
<h1>Pharmacology of Drugs on Urology</h1>

<h2>Medical Treatment of Benign Prostatic Hyperplasia</h2>

<ul title="medical treatment of benign prostatic hyperplasia">
<li>5alpha-reductase inhibitors
<ul>
<li><a href="https://www.urology-textbook.com/finasteride.html">Finasteride</a></li>
<li><a href="https://www.urology-textbook.com/dutasteride.html">Dutasteride</a></li>
</ul>
</li>
<li>Alpha blocker:
<ul>
<li><a href="https://www.urology-textbook.com/alpha-blocker.html">Alpha blockers: General pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/terazosin.html">Alpha blockers: Terazosin</a></li>
<li><a href="https://www.urology-textbook.com/doxazosin.html">Alpha blockers: Doxazosin</a></li>
<li><a href="https://www.urology-textbook.com/tamsulosin.html">Alpha blockers: Tamsulosin</a></li>
<li><a href="https://www.urology-textbook.com/alfuzosin.html">Alpha blockers: Alfuzosin</a></li>
<li><a href="https://www.urology-textbook.com/silodosin.html">Alpha blockers: Silodosin</a></li>
</ul>
</li>
<li>See also section <a href="https://www.urology-textbook.com/bph-treatment.html">medical treatment of benign prostatic hyperplasia</a></li>
</ul>

<h2>Analgetics</h2>

<ul>
<li>General principles of analgetics and pain perception</li>
<li>General principles of Opioids</li>
<li>Chronic pain</li>
<li>Diclofenac</li>
<li>Ibuprofen</li>
<li>Metamizol</li>
<li>Morphine</li>
<li>Piritramid</li>
</ul>

<h2>Androgene Deprivation Therapy</h2>

<p>Androgen deprivation therapy (ADT) is a treatment option for advanced prostate cancer in the following situations, please see section <a href="prostate-cancer-hormonal-therapy.html">metastatic prostate cancer</a> for details:</p>

    <ul>
        <li>Metastatic prostate cancer</li>
        <li>Biochemical progression of prostate cancer with no detectable metastases and a PSA doubling time below three months</li>
        <li>Adjuvant therapy of advanced prostate cancer after <a href="retropubic-radical-prostatectomy.html">radical prostatectomy</a> or <a href="prostate-cancer-radiation-therapy.html">radiation therapy</a></li>
        <li>Conservative treatment of locally advanced prostate cancer with LUTS</li>
        <li>Lowering prostate volume before <a href="prostate-cancer-brachytherapy.html">brachytherapy</a></li>
    </ul>
    
<h3>Classification of Drugs for Androgene Deprivation Therapy</h3>

    <ul>
        <li>Classic androgen receptor antagonists: nonsteroidal drugs are <a href="https://www.urology-textbook.com/bicalutamide.html">bicalutamide</a> and <a href="https://www.urology-textbook.com/flutamide.html">flutamide</a>. Cyproterone acetate is a classic steroidal antiandrogene with progestational effect, which causes additional central inhibition of the testosterone concentration. </li>
        <li><a href="https://www.urology-textbook.com/gnrh-agonists.html">GnRH agonists: Buserelin, Goserelin, Histrelin, Leuprorelin and Triptorelin</a></li>
        <li><a href="https://www.urology-textbook.com/gnrh-antagonists.html">GnRH antagonists: degarelix and abarelix</a></li>
        <li>Estrogens: Fosfestrol</li>
        <li>Androgen synthesis inhibitors: <a href="https://www.urology-textbook.com/abiraterone.html">Abiraterone</a>.</li>
        <li>Modern androgen receptor antagonists: <a href="https://www.urology-textbook.com/enzalutamide.html">Enzalutamide</a>, <a href="https://www.urology-textbook.com/apalutamide.html">Apalutamide</a>, <a href="https://www.urology-textbook.com/darolutamide.html">Darolutamide</a>.</li>
    </ul>

<h3>General Side Effects of Androgen Deprivation Therapy</h3>

<p>Androgen Deprivation Therapy (ADT) leads to significant side effects, especially in long-term use. Androgen receptor antagonists do not lower the testosterone concentration and cause less side effects (exection gynecomastia) to orchiectomy or GnRH modulators. General measures for the prevention of the side effects listed below are the increase in physical activity, striving for a normal body weight, vitamin-rich healthy diet and non-smoking (Nguyen et al., 2015).</p>

<h4>Hot flashes: </h4>
<p>Common side effect, this should only be treated in case of severe manifestation. Therapy options are (off-label use) Clonidin (1&nbsp;mg/d), Cyproteronacetat, Venlafaxin or Paroxetin (Loprinzi et al., 2004).</p>

<h4>Erectile dysfunction and loss of libido:</h4>
<p>ADT leads to severe erectile dysfunction (over 80%) and loss of libido (over 95%). Effective treatment of libido loss is not possible but the psychological burden of sexual dysfunction is low. Therapeutic options against erectile dysfunction (PDE5 inhibitors or SKAT) are not often requested. Long-term ADT leads to reductions in both penile and testicular size.</p>
 
<h4>Gynecomastia and mastodynia:</h4>
<p>A very common side effect with androgen receptor antagonists. When bicalutamide 150 mg is administered alone, the risk for gynecomastia is well over 70% after one year. The prophylactic single irradiation with 12&ndash;18&nbsp;Gy of the mammary glands before treatment significantly lowers the risk to 30&ndash;50 %. The risk of gynecomastia for combined hormone therapy is lower and amounts to about 20%. Gynecomastia is rare if GnRH modulators are used alone. </p>

<p>The prophylactic administration of tamoxifen (off-label) is more potent than the irradiation to reduce the frequency of gynecomastia (10% vs. 30&ndash;50%). The dosage of tamoxifen is 20&nbsp;mg/d. The effect of tamoxifen does not appear to affect hormone therapy and the biologic behavior of prostate cancer (Fradet et al., 2007). Another therapy option is subcutaneous mastectomy.</p>

<h4>Cognitive function and mood disorders:</h4>
<p>Cognitive function is disturbed by ADT. Furthermore, decreased libido, fatigue and episodes of depression (relative risk RR of 8) are more common.</p>

<h4>Metabolic changes:</h4>
<p>Androgen deprivation leads to a loss of muscle mass and increase in body fat, after a year the body weight has increased on average 2&ndash;4%. The risk of metabolic syndrome and type II diabetes is also significantly increased.</p>

<h4>Cardiovascular risks:</h4>
<p>Androgen deprivation leads to an increase in cardiovascular diseases (the relative risk in brackets): CHD (RR 1.2), myocardial infarction (RR 1.1), life-threatening cardiac arrhythmias or sudden cardiac death (RR 1.16). Cardiovascular mortality increases by 1&ndash;6% compared to the placebo group, depending on the study and follow-up period (Levine et al., 2010).</p>

<h4>Osteoporosis and fractures:</h4>
<p>Osteoporosis is a common complication of long-term ADT with GnRH modulators or castration (Diamond et al., 2004b). The administration of androgen receptor blockers (e.g., Bicalutamide) is not associated with osteoporosis (SmithMR et al, 2004). The fracture rate among men surviving at least 5 years is 19% with ADT versus 13% without ADT. All patients with a long-term prognosis should receive prophyactic vitamin D (800&ndash;1000&nbsp;IU) and calcium (1000&nbsp;mg). Additional treatment options for osteoporosis with increased fracture risk include bisphosphonates or denosumab.</p>

<h4>Anemia:</h4>
<p>Normochromic normocytic anemia develops in patients with long-term ADT, which responds well to erythropoietin (Choo et al., 2005).</p>

<h2>Antibiotics</h2>

<ul title="Antibiotics">
<li>&beta;-lactam antibiotics 
<ul>
<li>Penicillin</li>
<li><a href="https://www.urology-textbook.com/cephalosporins.html">Cephalosporins</a></li>
<li>Carbapenems</li>
</ul>
</li>

<li>Aminoglycoside</li>
<li>Tetracycline</li>
<li>Fluoroquinolones:

<ul>
<li><a href="https://www.urology-textbook.com/fluoroquinolones.html">Fluoroquinolones: general pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/ciprofloxacin.html">Fluoroquinolones: ciprofloxacin</a></li>
<li><a href="https://www.urology-textbook.com/levofloxacin.html">Fluoroquinolones: levofloxacin</a></li>
<li><a href="https://www.urology-textbook.com/ofloxacin.html">Fluoroquinolones: ofloxacin</a></li>
<li><a href="https://www.urology-textbook.com/norfloxacin.html">Fluoroquinolones: norfloxacin</a></li>
</ul>

</li>
<li>Macrolide antibiotics</li>
<li><a href="https://www.urology-textbook.com/fosfomycin.html">Fosfomycin</a></li>
<li><a href="https://www.urology-textbook.com/co-trimoxazole.html">Cotrimoxazole</a></li>
<li><a href="https://www.urology-textbook.com/metronidazole.html">Metronidazole</a></li>
</ul>


<h2>Anticholinergics</h2><ul title="Anticholinergics">
<li><a href="https://www.urology-textbook.com/anticholinergics.html">Anticholinergics (1/9): general pharmacology</a> </li>
<li><a href="https://www.urology-textbook.com/trospium-chloride.html">Anticholinergics (2/9): trospium chloride</a> </li>
<li>Anticholinergics (3/9): oxybutynin</li>
<li>Anticholinergics (4/9): tolterodine</li>
<li>Anticholinergics (5/9): fesoterodine</li>
<li>Anticholinergics (6/9): propiverine</li>
<li>Anticholinergics (7/9): darifenacin</li>
<li>Anticholinergics (8/9): solifenacin</li>
<li>Anticholinergics (9/9): butylscopolamine</li>
</ul>

<h2>Chemotherapy of Urologic Tumors</h2>

<ul title="Chemotherapy">
<li><a href="https://www.urology-textbook.com/bleomycin.html">Bleomycin</a></li>
<li>Cabazitaxel</li>
<li>Carboplatin</li>
<li>Cisplatin</li>
<li><a href="https://www.urology-textbook.com/docetaxel.html">Docetaxel</a></li>
<li>Estramustin</li>
<li>Etoposid</li>
<li>Gemcitabin</li>
<li>Mitomycin C</li>
<li>Vinflunin</li>
    </ul>

<h3>Chemotherapy Regimens in Urology</h3>
<ul>
<li>PEB regimen</li>
<li>PEI regimen</li>
<li><a href="https://www.urology-textbook.com/mvac.html">MVAC regimen</a></li>
<li>Cisplatin-Gemcitabin regimen</li>
</ul>

<h2>Targeted Tumor Therapy</h2>

<p>Targeted tumor therapy uses drugs against specific metabolic processes in tumor tissue that are of minimal importance in healthy cells. Monoclonal antibodies (suffix "mab") or low-molecular compounds (suffix "mib" or "nib") are used. Targeted drug-based tumor therapy is better tolerated than conventional chemotherapy and can be prescribed for years.</p>

<ul>
    <li><a href="https://www.urology-textbook.com/axitinib.html">Axitinib</a></li>
<li>Bevacizumab</li>
<li>Everolimus</li>
<li>Pazopanib</li>
<li>PARP Inhibitors
<ul>
    <li>Olaparib</li>
    <li>Niraparib</li>
    <li>Talazoparib</li>
</ul>
</li>
<li>Sorafenib</li>
<li>Sunitinib</li>
<li>Temsirolimus</li>
</ul>

<h2>Cancer Immunotherapy</h2>

<p>Tumour cells are recognized by the immune system as altered body cells and are eliminated. However, tumors have developed various strategies to evade the immune system. Several mechanisms can be used to stimulate the body's immune system to attack tumor cells again.</p>

<h4>Vaccinations:</h4>
<p>Examples of specific immunization in urology include vaccination against HPV for the prophylaxis of cervical and <a href="https://www.urology-textbook.com/penile-cancer.html">penile carcinoma</a> or experimental immunotherapy of <a href="https://www.urology-textbook.com/prostate-cancer.html">prostate carcinoma</a> with Sipuleucel-T (vaccination with activated autologous dendritic cells).</p>

<h4>Immune Checkpoints:</h4>
<p>Immune checkpoints are molecular biological "brakes" on the immune system. Tumors can influence immune checkpoints through the expression of proteins and thus evade elimination. Important immune checkpoints in urology are the programmed cell death-1 receptor and its ligand PD-L1 or the cytotoxic T lymphocyte antigen (CTLA)-4 receptor. Checkpoint inhibitors (CPIs) are mainly used to treat <a href="https://www.urology-textbook.com/bladder-cancer-chemotherapy.html">advanced bladder cancer</a> and <a href="https://www.urology-textbook.com/renal-cell-carcinoma-targeted-therapy.html">metastatic renal cell carcinoma</a>.</p>

<h4>Non-specific Activation:</h4> 
<p>Examples include <a href="https://www.urology-textbook.com/bladder-cancer-treatment.html">intravesical immunotherapy of bladder cancer with BCG</a> or parenteral administration of e.g. interferon-alpha and interleukin-2 for the <a href="https://www.urology-textbook.com/renal-cell-carcinoma-targeted-therapy.html">treatment of metastatic renal cell carcinoma</a>.</p>

<h2>Contrast Medium</h2>

<ul>
<li>Contrast medium for radiology</li>
</ul>

<h2>Local Anesthetics</h2>

<h2>Phosphodiesterase Inhibitors</h2>

<ul title="phosphodiesterase inhibitors">
<li><a href="https://www.urology-textbook.com/phosphodiesterase-inhibitors.html">Phosphodiesterase inhibitors: basic pharmacology</a></li>
<li><a href="https://www.urology-textbook.com/sildenafil.html">Sildenafil</a></li>
<li><a href="https://www.urology-textbook.com/tadalafil.html">Tadalafil</a></li>
<li><a href="https://www.urology-textbook.com/vardenafil.html">Vardenafil</a></li>
</ul>

<h2>Substances with Influence on the Acid-Base Balance</h2>

<ul>
<li>Alkali citrates</li>
<li>Methionin</li>
</ul>

<h2>Miscellaneous Drugs</h2>

<ul title="miscellaneous drugs">
<li>Tuberculostatic drugs</li>
<li><a href="https://www.urology-textbook.com/duloxetine.html">Duloxetine</a></li>
<li><a href="https://www.urology-textbook.com/dapoxetine.html">Dapoxetine</a></li>
<li><a href="https://www.urology-textbook.com/desmopressin.html">Desmopressin</a></li>
</ul>
 
 
<br>
<br>

<div id="ad-footer">
<!-- ad-footer -->
<ins class="adsbygoogle"
     style="display:inline-block;width:500px;height:250px"
     data-ad-client="ca-pub-9284927104423861"
     data-ad-slot="8746163219"></ins>
 <script>
     (adsbygoogle = window.adsbygoogle || []).push({});
</script>
</div>
<br><table id="navigation_unten">
<tr>
 
<td><a href="https://www.urology-textbook.com/surgical-management.html">Surgical management</a></td>
<td><a class="nav4" href="https://www.urology-textbook.com/index-urology.html">Index</a></td>
<td><a class="nav3" href="https://www.urology-textbook.com/kidneys.html">Kidneys</a></td>
 
</tr>
</table>

<br>
<br>
Index: <a href="https://www.urology-textbook.com/index-urology-a.html">1&ndash;9</a> <a href="https://www.urology-textbook.com/index-urology-a.html">A</a> <a href="https://www.urology-textbook.com/index-urology-b.html">B</a> <a href="https://www.urology-textbook.com/index-urology-c.html">C</a> <a href="https://www.urology-textbook.com/index-urology-d.html">D</a> <a href="https://www.urology-textbook.com/index-urology-e.html">E</a> <a href="https://www.urology-textbook.com/index-urology-f.html">F</a> <a href="https://www.urology-textbook.com/index-urology-g.html">G</a> <a href="https://www.urology-textbook.com/index-urology-h.html">H</a> <a href="https://www.urology-textbook.com/index-urology-i.html">I</a> <a href="https://www.urology-textbook.com/index-urology-j.html">J</a> <a href="https://www.urology-textbook.com/index-urology-k.html">K</a> <a href="https://www.urology-textbook.com/index-urology-l.html">L</a> <a href="https://www.urology-textbook.com/index-urology-m.html">M</a> <a href="https://www.urology-textbook.com/index-urology-n.html">N</a> <a href="https://www.urology-textbook.com/index-urology-o.html">O</a> <a href="https://www.urology-textbook.com/index-urology-p.html">P</a> <a href="https://www.urology-textbook.com/index-urology-q.html">Q</a> <a href="https://www.urology-textbook.com/index-urology-r.html">R</a> <a href="https://www.urology-textbook.com/index-urology-s.html">S</a> <a href="https://www.urology-textbook.com/index-urology-t.html">T</a> <a href="https://www.urology-textbook.com/index-urology-u.html">U</a> <a href="https://www.urology-textbook.com/index-urology-v.html">V</a> <a href="https://www.urology-textbook.com/index-urology-w.html">W</a> <a href="https://www.urology-textbook.com/index-urology-xyz.html">X Y Z</a> 

<br>
<br>

<p><img src="https://images0.urology-textbook.com/deutsch.gif">&nbsp; Deutsche Version: <a href="https://www.urologielehrbuch.de/grundlagen_medikamente.html">Medikamente in der Urologie</a></p>

</article>
</main>
<footer class="grid">
    <ul id="footer-nav">
    		<li>Copyright by Dr. med. Dirk Manski </li>
		<li><a href="https://www.urology-textbook.com/privacy-policy.html">Privacy policy</a></li>
		<li><a href="https://www.urology-textbook.com/disclaimer.html">Disclaimer</a></li>
	</ul>
	<a class="steady-login-button" data-size="medium" data-language="en" style="display: none;"></a>
</footer>
</body>
</html>
